R&D-Based Industry Describes Practical Challenges Of EU Paediatric Regulation
Executive Summary
From negotiating time-consuming pediatric investigation plans, to worrying about reimbursement issues, to getting things in order to secure a reward that will compensate the additional investment in pediatric research – the research-based pharmaceutical industry describes some of the practical challenges it faces in complying with the EU Paediatric Regulation.